Product Specifications
Below are the key product attributes and specifications that provide detailed information about this item:
Product Overview
The McKesson - 00115148801 - Mixed Amphetamine Salts Extended-Release Capsule 15mg CII is a prescription medication formulated to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. This extended-release capsule provides a controlled delivery of mixed amphetamine salts, ensuring sustained symptom management throughout the day.
Features:
- Extended-Release Formula: Delivers a steady dose of medication for prolonged effect.
- Precise Dosage: Each capsule contains 15mg of mixed amphetamine salts for accurate dosing.
- CII Controlled Substance: Requires a prescription due to its potential for dependence.
- Trusted Manufacturer: Produced by McKesson, a reputable pharmaceutical supplier.
Specifications:
- Active Ingredients: Mixed amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate).
- Dosage Form: Extended-release capsule.
- Strength: 15mg.
- DEA Schedule: CII (controlled substance).
- Packaging: Bottle or blister pack (quantity may vary).
Use Suggestion:
Take this medication as prescribed by a healthcare provider, typically once daily in the morning. Swallow the capsule whole with water; do not crush or chew. Avoid late-day dosing to prevent sleep disturbances. Regular monitoring by a physician is recommended to assess effectiveness and adjust dosage if needed.
